Tempus AI Inc (NASDAQ: TEM) is a precision medicine company using AI and data to improve cancer diagnosis and treatment. By integrating genomic, clinical, and imaging data, Tempus helps physicians personalise care plans. With a growing diagnostics business, pharma partnerships, and expansion into neuro and cardiology, Tempus is building a real-time operating system for healthcare — blending software margins with clinical relevance.